ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung-Reference-Cited by-同舟云学术

ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung

Published:2014-05 Issue:5 Volume:9 Page:729-732
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Caliò Anna,Nottegar Alessia,Gilioli Eliana,Bria Emilio,Pilotto Sara,Peretti Umberto,Kinspergher Stefania,Simionato Francesca,Pedron Serena,Knuutila Sakari,Tortora Giampaolo,Eccher Albino,Santo Antonio,Tondulli Luca,Inghirami Giorgio,Tabbò Fabrizio,Martignoni Guido,Chilosi Marco,Scarpa Aldo,Brunelli Matteo

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference15 articles.

1. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

2. A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations;Alrifai;Lung Cancer,2013

3. ALK rearrangement in a pure squamous cell carcinoma: the challenge of detection of ALK rearrangement;Kim;Virchows Arch,2013

4. Can we eliminate squamous cell carcinoma of the lung from testing of EML4-ALK fusion gene?;Ochi;Lung Cancer,2013

5. ALK translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers;Klempner;J Thorac Oncol,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation;Thoracic Cancer;2024-09-10

2. Primary Lung Squamous Cell Carcinoma With Intestinal Metastasis: A Case Report and Literature Review;The Clinical Respiratory Journal;2024-08

3. ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies;Cancer Drug Resistance;2024-05-23

4. Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma;Frontiers in Oncology;2024-04-12

5. Lung Cancer;Side Effects of Cancer Therapy;2024